Differences between women and men with gout in diagnostic evaluation and surveillance during the period under study
| Test | Men | Women | Unadjusted | Adjusted* | ||
|---|---|---|---|---|---|---|
| n | % | n | % | OR (95% CI) | OR (95% CI) | |
| *Adjusted for age, number of encounters with a gout diagnosis, gout-associated comorbidities (including hypertension, dyslipidaemia, coronary heart disease, peripheral arterial disease, diabetes mellitus, nephrolithiasis, renal insufficiency and renal failure), use of diuretics and health plan. | ||||||
| Serum urate | 3327 | 67 | 795 | 69 | 1.09 (0.95 to 1.25) | 1.20 (1.02 to 1.40 |
| 24-h urine for uric acid excretion | 245 | 5 | 67 | 6 | 1.19 (0.90 to 1.57) | 1.40 (1.04 to 1.90) |
| Synovial fluid cell count | 226 | 5 | 34 | 3 | 0.64 (0.44 to 0.92) | 0.56 (0.38 to 0.83) |
| Synovial crystal analysis | 245 | 5 | 32 | 2 | 0.56 (0.38 to 0.80) | 0.49 (0.34 to 0.72) |
| Diagnostic aspirations or therapeutic joint or bursal injections | 771 | 15 | 217 | 19 | 1.26 (1.07 to 1.49) | 1.10 (0.91 to 1.32) |